Table 2.
EGD | Colonoscopy | |||||
---|---|---|---|---|---|---|
Diarrhea | Control | p value | Diarrhea | Control | p value | |
Age | 0.38 | <0.001 | ||||
50–59 | 139 (18) | 640 (82) | 290 (5) | 5331 (95) | ||
60–69 | 140 (18) | 623 (82) | 297 (7) | 3844 (93) | ||
70+ | 114 (21) | 432 (79) | 280 (11) | 2386 (89) | ||
Gender | ||||||
Female | 285 (21) | 1079 (79) | <0.001 | 608 (8) | 6779 (92) | <0.001 |
Male | 108 (15) | 616 (85) | 259 (5) | 4782 (95) | ||
Any anti-hypertensive | 158 (16) | 810 (84) | 0.006 | 369 (7) | 4898 (93) | 0.91 |
No anti-hypertensive | 235 (21) | 885 (79) | 498 (7) | 6663 (93) | ||
Olmesartan | 7 (32) | 15 (68) | 0.12 | 4 (5) | 79 (95) | 0.44 |
Any ARB | 34 (15) | 194 (85) | 0.11 | 87 (8) | 961 (92) | 0.08 |
Any ACEI | 60 (14) | 358 (86) | 0.009 | 142 (6) | 2093 (94) | 0.20 |
HCTZ/Chlorthalidone | 34 (16) | 184 (84) | 0.20 | 84 (5) | 1455 (95) | 0.01 |
Beta Blocker | 74 (18) | 330 (82) | 0.77 | 175 (8) | 2070 (92) | 0.09 |
Calcium Channel Blocker | 22 (13) | 149 (87) | 0.04 | 66 (7) | 855 (93) | 0.81 |
Exposures meeting statistical significance are shown in bold.